• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

何时应使用有效治疗方法?治疗所需阈值数量和治疗最小事件发生率的推导。

When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.

作者信息

Sinclair J C, Cook R J, Guyatt G H, Pauker S G, Cook D J

机构信息

Department of Clinical Epidemiology and Biostatistics, McMaster University, Room 3N11F, 1200 Main Street West, Hamilton, L8N 3Z5, Ontario, Canada.

出版信息

J Clin Epidemiol. 2001 Mar;54(3):253-62. doi: 10.1016/s0895-4356(01)00347-x.

DOI:10.1016/s0895-4356(01)00347-x
PMID:11223323
Abstract

Clinicians and patients must decide when treatment effects are large enough to more than offset the adverse effects and costs of therapy. Calculation of the number of patients one needs to treat (NNT) in order to prevent one patient from having the target event is one tool to help with this decision. Clinicians should treat patients when the NNT is lower than a threshold NNT at which point the therapeutic risk equals the therapeutic benefit. We aimed: (1) to identify the determinants of the threshold NNT, and (2) to derive equations for the explicit estimation of the threshold NNT and of the minimum expected rate of target event, without treatment, above which treatment is justified. We conceived the threshold number needed to treat to prevent one target event as the point at which the benefits of treating that number of patients equal the negative consequences of treating that same number of patients. After identifying the various elements comprising the treatment impact, we equated the benefits and negative consequences and solved the equation for threshold NNT. We then derived the minimum expected rate of target event which would justify treatment. We derived an equation that relates the threshold NNT to the treatment-attributable adverse event rates (AER) and the relative values (RV) of the adverse events compared to that of the target event prevented. Specifically, the threshold NNT, denoted NNT(T) is given by NNT(T) = 1/(AER(1).RV(1) +...+ AER(n).RV(n)). We also derived a more complex equation which addresses the costs incurred by treatment and costs avoided by preventing target events. Solving the equation that includes costs requires specifying both the value of preventing a target event and the values of adverse treatment effects in economic units. The threshold NNT and the relative risk reduction (RRR) for the target event determine the minimum target event rate above which treatment is justified. This minimum event rate for treatment is 1/(NNT(T).RRR). The values that clinicians and patients use determine the threshold NNT and therefore also the minimum target event rate, without treatment, above which treatment is justified. Quantification of the determinants of the threshold NNT and of the minimum event rate to justify treatment can assist clinicians and patients in the explicit use of underlying values when making treatment decisions.

摘要

临床医生和患者必须确定治疗效果何时足够大,足以抵消治疗的不良反应和成本。计算为预防一名患者发生目标事件所需治疗的患者数量(NNT)是帮助做出这一决策的一种工具。当NNT低于某个阈值NNT时,临床医生应开始治疗,此时治疗风险等于治疗获益。我们的目标是:(1)确定阈值NNT的决定因素;(2)推导用于明确估计阈值NNT以及未治疗时目标事件的最低预期发生率的方程,高于该发生率治疗才合理。我们将预防一次目标事件所需治疗的阈值数量设想为治疗该数量患者的获益等于治疗相同数量患者的负面后果的那个点。在确定构成治疗影响的各种因素后,我们使获益与负面后果相等,并求解阈值NNT的方程。然后我们推导出了证明治疗合理的目标事件的最低预期发生率。我们推导了一个将阈值NNT与治疗归因的不良事件发生率(AER)以及不良事件与预防的目标事件相比的相对值(RV)相关联的方程。具体而言,阈值NNT(记为NNT(T))由NNT(T) = 1/(AER(1).RV(1) +... + AER(n).RV(n))给出。我们还推导了一个更复杂的方程,该方程考虑了治疗产生的成本以及预防目标事件所避免的成本。求解包含成本的方程需要指定预防目标事件的价值以及经济单位中不良治疗效果的价值。阈值NNT和目标事件的相对风险降低(RRR)决定了证明治疗合理的最低目标事件发生率。治疗的这个最低事件发生率为1/(NNT(T).RRR)。临床医生和患者所使用的值决定了阈值NNT,因此也决定了未治疗时证明治疗合理的最低目标事件发生率。对阈值NNT的决定因素以及证明治疗合理的最低事件发生率进行量化,可以帮助临床医生和患者在做出治疗决策时明确使用潜在价值。

相似文献

1
When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.何时应使用有效治疗方法?治疗所需阈值数量和治疗最小事件发生率的推导。
J Clin Epidemiol. 2001 Mar;54(3):253-62. doi: 10.1016/s0895-4356(01)00347-x.
2
Uncertainty in the minimum event risk to justify treatment was evaluated.评估了证明治疗合理所需的最低事件风险的不确定性。
J Clin Epidemiol. 2009 Aug;62(8):816-24. doi: 10.1016/j.jclinepi.2008.09.017. Epub 2009 Feb 12.
3
Weighing risks and benefits in treating the individual patient.
Clin Perinatol. 2003 Jun;30(2):251-68. doi: 10.1016/s0095-5108(03)00023-x.
4
Linking evidence-based medicine therapeutic summary measures to clinical decision analysis.将循证医学治疗总结指标与临床决策分析相联系。
MedGenMed. 2000 Jan 13;2(1):E6.
5
Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights.非维生素 K 口服抗凝剂与华法林用于房颤患者:绝对获益和危害评估带来新的见解。
Cardiovasc Ther. 2016 Apr;34(2):100-6. doi: 10.1111/1755-5922.12173.
6
The 'number needed to treat' and the 'adjusted NNT' in health care decision-making.医疗保健决策中的“需治疗人数”与“调整后的需治疗人数”
J Health Serv Res Policy. 1998 Jan;3(1):44-9. doi: 10.1177/135581969800300110.
7
The number needed to treat needs an associated odds estimation.治疗所需人数需要一个相关的概率估计。
J Public Health (Oxf). 2004 Mar;26(1):84-7. doi: 10.1093/pubmed/fdh101.
8
'Unqualified success' and 'unmitigated failure': number-needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events.
Int J Epidemiol. 1996 Aug;25(4):704-12. doi: 10.1093/ije/25.4.704.
9
[Evidence grading system and its usage in clinical decision-making analysis].
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Apr;25(4):351-4.
10
The number remaining at risk: an adjunct to the number needed to treat.仍处于风险中的人数:治疗所需人数的一个辅助指标。
Can J Cardiol. 2002 Mar;18(3):254-8.

引用本文的文献

1
Number needed to isolate - a new population health metric to quantify transmission reductions from isolation interventions for infectious diseases.隔离所需人数——一种新的群体健康指标,用于量化传染病隔离干预措施所带来的传播减少情况。
Popul Health Metr. 2024 Dec 23;22(1):39. doi: 10.1186/s12963-024-00360-y.
2
Decision threshold models in medical decision making: a scoping literature review.医学决策中的决策阈值模型:范围文献综述。
BMC Med Inform Decis Mak. 2024 Sep 27;24(1):273. doi: 10.1186/s12911-024-02681-2.
3
Effect of alirocumab and evolocumab on all-cause mortality and major cardiovascular events: A meta-analysis focusing on the number needed to treat.
阿利西尤单抗和依洛尤单抗对全因死亡率和主要心血管事件的影响:一项聚焦于治疗所需人数的荟萃分析。
Front Cardiovasc Med. 2022 Dec 2;9:1016802. doi: 10.3389/fcvm.2022.1016802. eCollection 2022.
4
Inconclusive evidence for the efficacy of tranexamic acid in reducing transfusions, postoperative infection or hematoma formation after primary shoulder arthroplasty: A meta-analysis with trial sequential analysis.氨甲环酸在初次肩关节置换术后减少输血、术后感染或血肿形成方面疗效的证据不确凿:一项采用试验序贯分析的荟萃分析
Shoulder Elbow. 2021 Feb;13(1):38-50. doi: 10.1177/1758573219896794. Epub 2020 Jan 13.
5
Bayesian Statistics for Surgical Decision Making.贝叶斯统计在外科决策中的应用。
Surg Infect (Larchmt). 2021 Aug;22(6):620-625. doi: 10.1089/sur.2020.391. Epub 2020 Dec 31.
6
Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors.评估根据人口统计学和行为风险因素向与男性发生性关系的男男性行为者和跨性别女性亚人群推荐 PrEP 的政策的影响。
PLoS One. 2019 Sep 19;14(9):e0222183. doi: 10.1371/journal.pone.0222183. eCollection 2019.
7
Utility of the number needed to treat in paediatric haematological cancer randomised controlled treatment trials: a systematic review.治疗儿童血液系统癌症随机对照治疗试验中需要治疗的人数的效用:系统评价。
BMJ Open. 2019 Feb 20;9(2):e022839. doi: 10.1136/bmjopen-2018-022839.
8
Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer.在评估用于选择治疗的标志物时对协变量进行调整,并应用于指导雌激素受体阳性、淋巴结阳性乳腺癌的化疗。
Contemp Clin Trials. 2017 Dec;63:30-39. doi: 10.1016/j.cct.2017.08.004. Epub 2017 Aug 14.
9
Expected utility versus expected regret theory versions of decision curve analysis do generate different results when treatment effects are taken into account.当考虑治疗效果时,决策曲线分析的预期效用与预期遗憾理论版本确实会产生不同的结果。
J Eval Clin Pract. 2018 Feb;24(1):65-71. doi: 10.1111/jep.12676. Epub 2016 Dec 15.
10
How do researchers determine the difference to be detected in superiority trials? Results of a survey from a panel of researchers.研究人员如何确定优效性试验中要检测的差异?一组研究人员的调查结果。
BMC Med Res Methodol. 2016 Jul 29;16:89. doi: 10.1186/s12874-016-0195-2.